ICU Medical Net Profit Margin 2010-2025 | ICUI

ICU Medical net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
ICU Medical Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2025-03-31 $2.42B $-0.09B -3.84%
2024-12-31 $2.38B $-0.12B -4.91%
2024-09-30 $2.34B $-0.11B -4.70%
2024-06-30 $2.30B $-0.07B -3.04%
2024-03-31 $2.26B $-0.06B -2.61%
2023-12-31 $2.26B $-0.03B -1.33%
2023-09-30 $2.25B $-0.03B -1.29%
2023-06-30 $2.29B $-0.05B -2.14%
2023-03-31 $2.31B $-0.05B -1.99%
2022-12-31 $2.28B $-0.07B -3.25%
2022-09-30 $2.04B $-0.04B -1.86%
2022-06-30 $1.78B $0.01B 0.34%
2022-03-31 $1.54B $0.04B 2.66%
2021-12-31 $1.32B $0.10B 7.82%
2021-09-30 $1.30B $0.11B 8.41%
2021-06-30 $1.28B $0.10B 8.05%
2021-03-31 $1.26B $0.09B 7.46%
2020-12-31 $1.27B $0.09B 6.85%
2020-09-30 $1.27B $0.08B 6.47%
2020-06-30 $1.26B $0.08B 6.69%
2020-03-31 $1.26B $0.09B 6.96%
2019-12-31 $1.27B $0.10B 8.06%
2019-09-30 $1.29B $0.07B 5.74%
2019-06-30 $1.31B $0.05B 3.59%
2019-03-31 $1.36B $0.06B 4.05%
2018-12-31 $1.40B $0.03B 2.07%
2018-09-30 $1.43B $0.09B 6.02%
2018-06-30 $1.45B $0.09B 5.95%
2018-03-31 $1.42B $0.02B 1.27%
2017-12-31 $1.29B $0.07B 5.34%
2017-09-30 $1.02B $0.03B 2.85%
2017-06-30 $0.77B $0.05B 6.21%
2017-03-31 $0.54B $0.10B 18.96%
2016-12-31 $0.38B $0.06B 16.84%
2016-09-30 $0.37B $0.06B 15.78%
2016-06-30 $0.36B $0.06B 15.43%
2016-03-31 $0.35B $0.05B 15.14%
2015-12-31 $0.34B $0.05B 13.20%
2015-09-30 $0.33B $0.05B 14.20%
2015-06-30 $0.32B $0.04B 11.49%
2015-03-31 $0.32B $0.03B 9.15%
2014-12-31 $0.31B $0.03B 8.41%
2014-09-30 $0.31B $0.03B 10.42%
2014-06-30 $0.31B $0.04B 11.82%
2014-03-31 $0.31B $0.04B 12.14%
2013-12-31 $0.31B $0.04B 12.74%
2013-09-30 $0.32B $0.04B 12.23%
2013-06-30 $0.32B $0.04B 12.62%
2013-03-31 $0.32B $0.04B 13.33%
2012-12-31 $0.32B $0.04B 12.93%
2012-09-30 $0.31B $0.05B 15.16%
2012-06-30 $0.31B $0.04B 14.43%
2012-03-31 $0.31B $0.04B 14.38%
2011-12-31 $0.30B $0.04B 14.62%
2011-09-30 $0.30B $0.04B 11.71%
2011-06-30 $0.30B $0.04B 11.71%
2011-03-31 $0.29B $0.03B 11.72%
2010-12-31 $0.28B $0.03B 10.60%
2010-09-30 $0.28B $0.03B 9.78%
2010-06-30 $0.25B $0.02B 9.45%
2010-03-31 $0.24B $0.02B 9.24%
2009-12-31 $0.23B $0.03B 10.96%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.253B $2.382B
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.693B 27.62
Boston Scientific (BSX) United States $152.679B 38.22
Stryker (SYK) United States $148.653B 31.08
EssilorLuxottica (ESLOY) France $131.422B 0.00
Medtronic (MDT) Ireland $115.326B 16.35
Lonza Group Ag (LZAGY) Switzerland $49.666B 0.00
Haleon (HLN) United Kingdom $44.744B 25.54
ResMed (RMD) United States $37.302B 28.02
Agilent Technologies (A) United States $35.020B 22.83
GE HealthCare Technologies (GEHC) United States $34.401B 16.33
Terumo (TRUMY) Japan $24.607B 31.96
Koninklijke Philips (PHG) Netherlands $23.139B 16.24
Insulet (PODD) United States $20.361B 79.92
Zimmer Biomet Holdings (ZBH) United States $18.556B 11.92
Baxter (BAX) United States $14.728B 11.00
Smith & Nephew SNATS (SNN) United Kingdom $13.262B 0.00
Demant (WILYY) Denmark $8.971B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.993B 24.33
Lantheus Holdings (LNTH) United States $5.626B 14.19
Perrigo (PRGO) Ireland $3.785B 9.59
Prestige Consumer Healthcare (PBH) United States $3.780B 16.89
Haemonetics (HAE) United States $3.628B 16.52
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.424B 28.45
QuidelOrtho (QDEL) United States $2.052B 14.11
LeMaitre Vascular (LMAT) United States $1.891B 42.26
AtriCure (ATRC) United States $1.521B 0.00
Acuren (TIC) United States $1.395B 0.00
Green Thumb Industries (GTBIF) United States $1.389B 31.24
Phibro Animal Health (PAHC) United States $1.248B 15.96
AdaptHealth (AHCO) United States $1.244B 12.63
Neogen (NEOG) United States $1.170B 14.97
BioLife Solutions (BLFS) United States $1.050B 0.00
InMode (INMD) Israel $0.930B 9.37
Curaleaf Holdings (CURLF) Canada $0.771B 0.00
Kestra Medical Technologies (KMTS) United States $0.766B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.695B 0.00
Owens & Minor (OMI) United States $0.627B 5.21
Evolus (EOLS) United States $0.611B 0.00
Tilray Brands (TLRY) Canada $0.584B 0.00
CeriBell (CBLL) United States $0.583B 0.00
Valneva SE (VALN) France $0.517B 0.00
Surmodics (SRDX) United States $0.441B 0.00
SNDL (SNDL) Canada $0.365B 0.00
Capricor Therapeutics (CAPR) United States $0.349B 0.00
VAREX IMAGING (VREX) United States $0.337B 12.38
Cresco Labs (CRLBF) United States $0.323B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Sanuwave Health (SNWV) United States $0.298B 0.00
Quanterix (QTRX) United States $0.294B 0.00
Cerus (CERS) United States $0.277B 0.00
Viemed Healthcare (VMD) United States $0.266B 22.47
Sanara MedTech (SMTI) United States $0.258B 0.00
Aurora Cannabis (ACB) Canada $0.252B 74.83
ZimVie (ZIMV) United States $0.251B 11.39
Verano Holdings (VRNOF) United States $0.235B 0.00
Brainsway (BWAY) Israel $0.233B 61.55
OraSure Technologies (OSUR) United States $0.232B 0.00
Biote (BTMD) United States $0.223B 6.28
Omeros (OMER) United States $0.214B 0.00
Canopy Growth (CGC) Canada $0.208B 0.00
Organigram Global (OGI) Canada $0.194B 0.00
High Tide (HITI) Canada $0.191B 0.00
TriSalus Life Sciences (TLSI) United States $0.185B 0.00
Utah Medical Products (UTMD) United States $0.183B 14.93
Vireo Growth (VREOF) United States $0.163B 0.00
Exagen (XGN) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.122B 0.00
TerrAscend (TSNDF) Canada $0.117B 0.00
MacroGenics (MGNX) United States $0.102B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.098B 12.68
Jushi Holdings (JUSHF) United States $0.090B 0.00
Veru (VERU) United States $0.088B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.081B 0.00
Apyx Medical (APYX) United States $0.079B 0.00
Agape ATP (ATPC) $0.074B 0.00
InterCure (INCR) Israel $0.071B 0.00
Zynex (ZYXI) United States $0.068B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Rockwell Medical (RMTI) United States $0.039B 0.00
Modular Medical (MODD) United States $0.039B 0.00
Nephros (NEPH) United States $0.038B 51.43
United-Guardian (UG) United States $0.037B 12.89
Safety Shot (SHOT) United States $0.034B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
INLIF (INLF) $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00